Global Glucagon Market Growth 2025-2031

March 2025 | 88 pages | ID: G8F32E13573EN
LP Information

Abstracts

The report requires updating with new data and is sent in 48 hours after order is placed.

The global Glucagon market size is predicted to grow from US$ 645 million in 2025 to US$ 933 million in 2031; it is expected to grow at a CAGR of 6.3% from 2025 to 2031.

Glucagon is a metabolic hormone secreted by the pancreas that raises blood glucose levels by causing the liver to rapidly convert glycogen (the stored form of glucose) into glucose, which is then released into the bloodstream. Glucagon and insulin are two critical hormones in a glycemic control system that keeps blood glucose at the right level in healthy individual. Glucagon is a medicine which used to treat severe low blood sugar (hypoglycemia). Glucagon works by telling your body to release sugar (glucose) into the bloodstream to bring the blood sugar level back up.

Global Glucagon main players are Novo Nordisk, Eli Lilly, Fresenius Kabi, Torrent Labs, etc. Global top four manufacturers hold a share over 80%. North America is the largest market, with a share nearly 40%.

LP Information, Inc. (LPI) ' newest research report, the “Glucagon Industry Forecast” looks at past sales and reviews total world Glucagon sales in 2024, providing a comprehensive analysis by region and market sector of projected Glucagon sales for 2025 through 2031. With Glucagon sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Glucagon industry.

This Insight Report provides a comprehensive analysis of the global Glucagon landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Glucagon portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Glucagon market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Glucagon and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Glucagon.

This report presents a comprehensive overview, market shares, and growth opportunities of Glucagon market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:

• Inject Glucagon
• Nasal Glucagon

Segmentation by Application:

• Emergency Kits
• General Use
• Diagnostic & Motility
• Cardiogenic Shock
• Others

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.

• Novo Nordisk
• Eli Lilly
• Fresenius Kabi
• Torrent Labs
• Taj Pharmaceuticals
• Xeris Pharmaceuticals

Key Questions Addressed in this Report

What is the 10-year outlook for the global Glucagon market?

What factors are driving Glucagon market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Glucagon market opportunities vary by end market size?

How does Glucagon break out by Type, by Application?

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Glucagon Annual Sales 2020-2031
  2.1.2 World Current & Future Analysis for Glucagon by Geographic Region, 2020, 2024 & 2031
  2.1.3 World Current & Future Analysis for Glucagon by Country/Region, 2020, 2024 & 2031
2.2 Glucagon Segment by Type
  2.2.1 Inject Glucagon
  2.2.2 Nasal Glucagon
2.3 Glucagon Sales by Type
  2.3.1 Global Glucagon Sales Market Share by Type (2020-2025)
  2.3.2 Global Glucagon Revenue and Market Share by Type (2020-2025)
  2.3.3 Global Glucagon Sale Price by Type (2020-2025)
2.4 Glucagon Segment by Application
  2.4.1 Emergency Kits
  2.4.2 General Use
  2.4.3 Diagnostic & Motility
  2.4.4 Cardiogenic Shock
  2.4.5 Others
2.5 Glucagon Sales by Application
  2.5.1 Global Glucagon Sale Market Share by Application (2020-2025)
  2.5.2 Global Glucagon Revenue and Market Share by Application (2020-2025)
  2.5.3 Global Glucagon Sale Price by Application (2020-2025)

3 GLOBAL BY COMPANY

3.1 Global Glucagon Breakdown Data by Company
  3.1.1 Global Glucagon Annual Sales by Company (2020-2025)
  3.1.2 Global Glucagon Sales Market Share by Company (2020-2025)
3.2 Global Glucagon Annual Revenue by Company (2020-2025)
  3.2.1 Global Glucagon Revenue by Company (2020-2025)
  3.2.2 Global Glucagon Revenue Market Share by Company (2020-2025)
3.3 Global Glucagon Sale Price by Company
3.4 Key Manufacturers Glucagon Producing Area Distribution, Sales Area, Product Type
  3.4.1 Key Manufacturers Glucagon Product Location Distribution
  3.4.2 Players Glucagon Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy

4 WORLD HISTORIC REVIEW FOR GLUCAGON BY GEOGRAPHIC REGION

4.1 World Historic Glucagon Market Size by Geographic Region (2020-2025)
  4.1.1 Global Glucagon Annual Sales by Geographic Region (2020-2025)
  4.1.2 Global Glucagon Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Glucagon Market Size by Country/Region (2020-2025)
  4.2.1 Global Glucagon Annual Sales by Country/Region (2020-2025)
  4.2.2 Global Glucagon Annual Revenue by Country/Region (2020-2025)
4.3 Americas Glucagon Sales Growth
4.4 APAC Glucagon Sales Growth
4.5 Europe Glucagon Sales Growth
4.6 Middle East & Africa Glucagon Sales Growth

5 AMERICAS

5.1 Americas Glucagon Sales by Country
  5.1.1 Americas Glucagon Sales by Country (2020-2025)
  5.1.2 Americas Glucagon Revenue by Country (2020-2025)
5.2 Americas Glucagon Sales by Type (2020-2025)
5.3 Americas Glucagon Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Glucagon Sales by Region
  6.1.1 APAC Glucagon Sales by Region (2020-2025)
  6.1.2 APAC Glucagon Revenue by Region (2020-2025)
6.2 APAC Glucagon Sales by Type (2020-2025)
6.3 APAC Glucagon Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan

7 EUROPE

7.1 Europe Glucagon by Country
  7.1.1 Europe Glucagon Sales by Country (2020-2025)
  7.1.2 Europe Glucagon Revenue by Country (2020-2025)
7.2 Europe Glucagon Sales by Type (2020-2025)
7.3 Europe Glucagon Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Glucagon by Country
  8.1.1 Middle East & Africa Glucagon Sales by Country (2020-2025)
  8.1.2 Middle East & Africa Glucagon Revenue by Country (2020-2025)
8.2 Middle East & Africa Glucagon Sales by Type (2020-2025)
8.3 Middle East & Africa Glucagon Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 MANUFACTURING COST STRUCTURE ANALYSIS

10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Glucagon
10.3 Manufacturing Process Analysis of Glucagon
10.4 Industry Chain Structure of Glucagon

11 MARKETING, DISTRIBUTORS AND CUSTOMER

11.1 Sales Channel
  11.1.1 Direct Channels
  11.1.2 Indirect Channels
11.2 Glucagon Distributors
11.3 Glucagon Customer

12 WORLD FORECAST REVIEW FOR GLUCAGON BY GEOGRAPHIC REGION

12.1 Global Glucagon Market Size Forecast by Region
  12.1.1 Global Glucagon Forecast by Region (2026-2031)
  12.1.2 Global Glucagon Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Glucagon Forecast by Type (2026-2031)
12.7 Global Glucagon Forecast by Application (2026-2031)

13 KEY PLAYERS ANALYSIS

13.1 Novo Nordisk
  13.1.1 Novo Nordisk Company Information
  13.1.2 Novo Nordisk Glucagon Product Portfolios and Specifications
  13.1.3 Novo Nordisk Glucagon Sales, Revenue, Price and Gross Margin (2020-2025)
  13.1.4 Novo Nordisk Main Business Overview
  13.1.5 Novo Nordisk Latest Developments
13.2 Eli Lilly
  13.2.1 Eli Lilly Company Information
  13.2.2 Eli Lilly Glucagon Product Portfolios and Specifications
  13.2.3 Eli Lilly Glucagon Sales, Revenue, Price and Gross Margin (2020-2025)
  13.2.4 Eli Lilly Main Business Overview
  13.2.5 Eli Lilly Latest Developments
13.3 Fresenius Kabi
  13.3.1 Fresenius Kabi Company Information
  13.3.2 Fresenius Kabi Glucagon Product Portfolios and Specifications
  13.3.3 Fresenius Kabi Glucagon Sales, Revenue, Price and Gross Margin (2020-2025)
  13.3.4 Fresenius Kabi Main Business Overview
  13.3.5 Fresenius Kabi Latest Developments
13.4 Torrent Labs
  13.4.1 Torrent Labs Company Information
  13.4.2 Torrent Labs Glucagon Product Portfolios and Specifications
  13.4.3 Torrent Labs Glucagon Sales, Revenue, Price and Gross Margin (2020-2025)
  13.4.4 Torrent Labs Main Business Overview
  13.4.5 Torrent Labs Latest Developments
13.5 Taj Pharmaceuticals
  13.5.1 Taj Pharmaceuticals Company Information
  13.5.2 Taj Pharmaceuticals Glucagon Product Portfolios and Specifications
  13.5.3 Taj Pharmaceuticals Glucagon Sales, Revenue, Price and Gross Margin (2020-2025)
  13.5.4 Taj Pharmaceuticals Main Business Overview
  13.5.5 Taj Pharmaceuticals Latest Developments
13.6 Xeris Pharmaceuticals
  13.6.1 Xeris Pharmaceuticals Company Information
  13.6.2 Xeris Pharmaceuticals Glucagon Product Portfolios and Specifications
  13.6.3 Xeris Pharmaceuticals Glucagon Sales, Revenue, Price and Gross Margin (2020-2025)
  13.6.4 Xeris Pharmaceuticals Main Business Overview
  13.6.5 Xeris Pharmaceuticals Latest Developments

14 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Glucagon Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Glucagon Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Inject Glucagon
Table 4. Major Players of Nasal Glucagon
Table 5. Global Glucagon Sales by Type (2020-2025) & (K MT)
Table 6. Global Glucagon Sales Market Share by Type (2020-2025)
Table 7. Global Glucagon Revenue by Type (2020-2025) & ($ million)
Table 8. Global Glucagon Revenue Market Share by Type (2020-2025)
Table 9. Global Glucagon Sale Price by Type (2020-2025) & (USD/MT)
Table 10. Global Glucagon Sale by Application (2020-2025) & (K MT)
Table 11. Global Glucagon Sale Market Share by Application (2020-2025)
Table 12. Global Glucagon Revenue by Application (2020-2025) & ($ million)
Table 13. Global Glucagon Revenue Market Share by Application (2020-2025)
Table 14. Global Glucagon Sale Price by Application (2020-2025) & (USD/MT)
Table 15. Global Glucagon Sales by Company (2020-2025) & (K MT)
Table 16. Global Glucagon Sales Market Share by Company (2020-2025)
Table 17. Global Glucagon Revenue by Company (2020-2025) & ($ millions)
Table 18. Global Glucagon Revenue Market Share by Company (2020-2025)
Table 19. Global Glucagon Sale Price by Company (2020-2025) & (USD/MT)
Table 20. Key Manufacturers Glucagon Producing Area Distribution and Sales Area
Table 21. Players Glucagon Products Offered
Table 22. Glucagon Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Glucagon Sales by Geographic Region (2020-2025) & (K MT)
Table 26. Global Glucagon Sales Market Share Geographic Region (2020-2025)
Table 27. Global Glucagon Revenue by Geographic Region (2020-2025) & ($ millions)
Table 28. Global Glucagon Revenue Market Share by Geographic Region (2020-2025)
Table 29. Global Glucagon Sales by Country/Region (2020-2025) & (K MT)
Table 30. Global Glucagon Sales Market Share by Country/Region (2020-2025)
Table 31. Global Glucagon Revenue by Country/Region (2020-2025) & ($ millions)
Table 32. Global Glucagon Revenue Market Share by Country/Region (2020-2025)
Table 33. Americas Glucagon Sales by Country (2020-2025) & (K MT)
Table 34. Americas Glucagon Sales Market Share by Country (2020-2025)
Table 35. Americas Glucagon Revenue by Country (2020-2025) & ($ millions)
Table 36. Americas Glucagon Sales by Type (2020-2025) & (K MT)
Table 37. Americas Glucagon Sales by Application (2020-2025) & (K MT)
Table 38. APAC Glucagon Sales by Region (2020-2025) & (K MT)
Table 39. APAC Glucagon Sales Market Share by Region (2020-2025)
Table 40. APAC Glucagon Revenue by Region (2020-2025) & ($ millions)
Table 41. APAC Glucagon Sales by Type (2020-2025) & (K MT)
Table 42. APAC Glucagon Sales by Application (2020-2025) & (K MT)
Table 43. Europe Glucagon Sales by Country (2020-2025) & (K MT)
Table 44. Europe Glucagon Revenue by Country (2020-2025) & ($ millions)
Table 45. Europe Glucagon Sales by Type (2020-2025) & (K MT)
Table 46. Europe Glucagon Sales by Application (2020-2025) & (K MT)
Table 47. Middle East & Africa Glucagon Sales by Country (2020-2025) & (K MT)
Table 48. Middle East & Africa Glucagon Revenue Market Share by Country (2020-2025)
Table 49. Middle East & Africa Glucagon Sales by Type (2020-2025) & (K MT)
Table 50. Middle East & Africa Glucagon Sales by Application (2020-2025) & (K MT)
Table 51. Key Market Drivers & Growth Opportunities of Glucagon
Table 52. Key Market Challenges & Risks of Glucagon
Table 53. Key Industry Trends of Glucagon
Table 54. Glucagon Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Glucagon Distributors List
Table 57. Glucagon Customer List
Table 58. Global Glucagon Sales Forecast by Region (2026-2031) & (K MT)
Table 59. Global Glucagon Revenue Forecast by Region (2026-2031) & ($ millions)
Table 60. Americas Glucagon Sales Forecast by Country (2026-2031) & (K MT)
Table 61. Americas Glucagon Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 62. APAC Glucagon Sales Forecast by Region (2026-2031) & (K MT)
Table 63. APAC Glucagon Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 64. Europe Glucagon Sales Forecast by Country (2026-2031) & (K MT)
Table 65. Europe Glucagon Revenue Forecast by Country (2026-2031) & ($ millions)
Table 66. Middle East & Africa Glucagon Sales Forecast by Country (2026-2031) & (K MT)
Table 67. Middle East & Africa Glucagon Revenue Forecast by Country (2026-2031) & ($ millions)
Table 68. Global Glucagon Sales Forecast by Type (2026-2031) & (K MT)
Table 69. Global Glucagon Revenue Forecast by Type (2026-2031) & ($ millions)
Table 70. Global Glucagon Sales Forecast by Application (2026-2031) & (K MT)
Table 71. Global Glucagon Revenue Forecast by Application (2026-2031) & ($ millions)
Table 72. Novo Nordisk Basic Information, Glucagon Manufacturing Base, Sales Area and Its Competitors
Table 73. Novo Nordisk Glucagon Product Portfolios and Specifications
Table 74. Novo Nordisk Glucagon Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 75. Novo Nordisk Main Business
Table 76. Novo Nordisk Latest Developments
Table 77. Eli Lilly Basic Information, Glucagon Manufacturing Base, Sales Area and Its Competitors
Table 78. Eli Lilly Glucagon Product Portfolios and Specifications
Table 79. Eli Lilly Glucagon Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 80. Eli Lilly Main Business
Table 81. Eli Lilly Latest Developments
Table 82. Fresenius Kabi Basic Information, Glucagon Manufacturing Base, Sales Area and Its Competitors
Table 83. Fresenius Kabi Glucagon Product Portfolios and Specifications
Table 84. Fresenius Kabi Glucagon Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 85. Fresenius Kabi Main Business
Table 86. Fresenius Kabi Latest Developments
Table 87. Torrent Labs Basic Information, Glucagon Manufacturing Base, Sales Area and Its Competitors
Table 88. Torrent Labs Glucagon Product Portfolios and Specifications
Table 89. Torrent Labs Glucagon Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 90. Torrent Labs Main Business
Table 91. Torrent Labs Latest Developments
Table 92. Taj Pharmaceuticals Basic Information, Glucagon Manufacturing Base, Sales Area and Its Competitors
Table 93. Taj Pharmaceuticals Glucagon Product Portfolios and Specifications
Table 94. Taj Pharmaceuticals Glucagon Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 95. Taj Pharmaceuticals Main Business
Table 96. Taj Pharmaceuticals Latest Developments
Table 97. Xeris Pharmaceuticals Basic Information, Glucagon Manufacturing Base, Sales Area and Its Competitors
Table 98. Xeris Pharmaceuticals Glucagon Product Portfolios and Specifications
Table 99. Xeris Pharmaceuticals Glucagon Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 100. Xeris Pharmaceuticals Main Business
Table 101. Xeris Pharmaceuticals Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Picture of Glucagon
Figure 2. Glucagon Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Glucagon Sales Growth Rate 2020-2031 (K MT)
Figure 7. Global Glucagon Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Glucagon Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Glucagon Sales Market Share by Country/Region (2024)
Figure 10. Glucagon Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Inject Glucagon
Figure 12. Product Picture of Nasal Glucagon
Figure 13. Global Glucagon Sales Market Share by Type in 2025
Figure 14. Global Glucagon Revenue Market Share by Type (2020-2025)
Figure 15. Glucagon Consumed in Emergency Kits
Figure 16. Global Glucagon Market: Emergency Kits (2020-2025) & (K MT)
Figure 17. Glucagon Consumed in General Use
Figure 18. Global Glucagon Market: General Use (2020-2025) & (K MT)
Figure 19. Glucagon Consumed in Diagnostic & Motility
Figure 20. Global Glucagon Market: Diagnostic & Motility (2020-2025) & (K MT)
Figure 21. Glucagon Consumed in Cardiogenic Shock
Figure 22. Global Glucagon Market: Cardiogenic Shock (2020-2025) & (K MT)
Figure 23. Glucagon Consumed in Others
Figure 24. Global Glucagon Market: Others (2020-2025) & (K MT)
Figure 25. Global Glucagon Sale Market Share by Application (2024)
Figure 26. Global Glucagon Revenue Market Share by Application in 2025
Figure 27. Glucagon Sales by Company in 2025 (K MT)
Figure 28. Global Glucagon Sales Market Share by Company in 2025
Figure 29. Glucagon Revenue by Company in 2025 ($ millions)
Figure 30. Global Glucagon Revenue Market Share by Company in 2025
Figure 31. Global Glucagon Sales Market Share by Geographic Region (2020-2025)
Figure 32. Global Glucagon Revenue Market Share by Geographic Region in 2025
Figure 33. Americas Glucagon Sales 2020-2025 (K MT)
Figure 34. Americas Glucagon Revenue 2020-2025 ($ millions)
Figure 35. APAC Glucagon Sales 2020-2025 (K MT)
Figure 36. APAC Glucagon Revenue 2020-2025 ($ millions)
Figure 37. Europe Glucagon Sales 2020-2025 (K MT)
Figure 38. Europe Glucagon Revenue 2020-2025 ($ millions)
Figure 39. Middle East & Africa Glucagon Sales 2020-2025 (K MT)
Figure 40. Middle East & Africa Glucagon Revenue 2020-2025 ($ millions)
Figure 41. Americas Glucagon Sales Market Share by Country in 2025
Figure 42. Americas Glucagon Revenue Market Share by Country (2020-2025)
Figure 43. Americas Glucagon Sales Market Share by Type (2020-2025)
Figure 44. Americas Glucagon Sales Market Share by Application (2020-2025)
Figure 45. United States Glucagon Revenue Growth 2020-2025 ($ millions)
Figure 46. Canada Glucagon Revenue Growth 2020-2025 ($ millions)
Figure 47. Mexico Glucagon Revenue Growth 2020-2025 ($ millions)
Figure 48. Brazil Glucagon Revenue Growth 2020-2025 ($ millions)
Figure 49. APAC Glucagon Sales Market Share by Region in 2025
Figure 50. APAC Glucagon Revenue Market Share by Region (2020-2025)
Figure 51. APAC Glucagon Sales Market Share by Type (2020-2025)
Figure 52. APAC Glucagon Sales Market Share by Application (2020-2025)
Figure 53. China Glucagon Revenue Growth 2020-2025 ($ millions)
Figure 54. Japan Glucagon Revenue Growth 2020-2025 ($ millions)
Figure 55. South Korea Glucagon Revenue Growth 2020-2025 ($ millions)
Figure 56. Southeast Asia Glucagon Revenue Growth 2020-2025 ($ millions)
Figure 57. India Glucagon Revenue Growth 2020-2025 ($ millions)
Figure 58. Australia Glucagon Revenue Growth 2020-2025 ($ millions)
Figure 59. China Taiwan Glucagon Revenue Growth 2020-2025 ($ millions)
Figure 60. Europe Glucagon Sales Market Share by Country in 2025
Figure 61. Europe Glucagon Revenue Market Share by Country (2020-2025)
Figure 62. Europe Glucagon Sales Market Share by Type (2020-2025)
Figure 63. Europe Glucagon Sales Market Share by Application (2020-2025)
Figure 64. Germany Glucagon Revenue Growth 2020-2025 ($ millions)
Figure 65. France Glucagon Revenue Growth 2020-2025 ($ millions)
Figure 66. UK Glucagon Revenue Growth 2020-2025 ($ millions)
Figure 67. Italy Glucagon Revenue Growth 2020-2025 ($ millions)
Figure 68. Russia Glucagon Revenue Growth 2020-2025 ($ millions)
Figure 69. Middle East & Africa Glucagon Sales Market Share by Country (2020-2025)
Figure 70. Middle East & Africa Glucagon Sales Market Share by Type (2020-2025)
Figure 71. Middle East & Africa Glucagon Sales Market Share by Application (2020-2025)
Figure 72. Egypt Glucagon Revenue Growth 2020-2025 ($ millions)
Figure 73. South Africa Glucagon Revenue Growth 2020-2025 ($ millions)
Figure 74. Israel Glucagon Revenue Growth 2020-2025 ($ millions)
Figure 75. Turkey Glucagon Revenue Growth 2020-2025 ($ millions)
Figure 76. GCC Countries Glucagon Revenue Growth 2020-2025 ($ millions)
Figure 77. Manufacturing Cost Structure Analysis of Glucagon in 2025
Figure 78. Manufacturing Process Analysis of Glucagon
Figure 79. Industry Chain Structure of Glucagon
Figure 80. Channels of Distribution
Figure 81. Global Glucagon Sales Market Forecast by Region (2026-2031)
Figure 82. Global Glucagon Revenue Market Share Forecast by Region (2026-2031)
Figure 83. Global Glucagon Sales Market Share Forecast by Type (2026-2031)
Figure 84. Global Glucagon Revenue Market Share Forecast by Type (2026-2031)
Figure 85. Global Glucagon Sales Market Share Forecast by Application (2026-2031)
Figure 86. Global Glucagon Revenue Market Share Forecast by Application (2026-2031)